X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (69) 69
life sciences & biomedicine (66) 66
humans (56) 56
male (33) 33
female (27) 27
oncology (26) 26
aged (24) 24
hematology (22) 22
middle aged (22) 22
chemotherapy (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
adult (15) 15
cancer (13) 13
prednisone (13) 13
care and treatment (12) 12
corticosteroids (12) 12
patients (12) 12
abridged index medicus (11) 11
doxorubicin (11) 11
drug therapy (11) 11
lymphomas (11) 11
multiple myeloma (11) 11
treatment outcome (11) 11
adolescent (10) 10
multiple myeloma - drug therapy (10) 10
prognosis (10) 10
rituximab (10) 10
aged, 80 and over (9) 9
cyclophosphamide (9) 9
disease-free survival (9) 9
umcg approved (9) 9
vincristine (9) 9
antineoplastic combined chemotherapy protocols - administration & dosage (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
retrospective studies (8) 8
survival rate (8) 8
thalidomide (8) 8
elderly-patients (7) 7
multiple myeloma - mortality (7) 7
prednisone - therapeutic use (7) 7
research (7) 7
therapy (7) 7
cyclophosphamide - administration & dosage (6) 6
cyclophosphamide - therapeutic use (6) 6
diffuse large b-cell lymphoma (6) 6
drug therapy, combination (6) 6
general & internal medicine (6) 6
lymphoma (6) 6
medicine, general & internal (6) 6
neutropenia (6) 6
patient outcomes (6) 6
pediatrics (6) 6
randomized controlled-trial (6) 6
safety (6) 6
thalidomide - therapeutic use (6) 6
vincristine - administration & dosage (6) 6
antineoplastic agents - therapeutic use (5) 5
bortezomib (5) 5
child (5) 5
children (5) 5
clinical trials (5) 5
combined modality therapy (5) 5
development and progression (5) 5
dexamethasone (5) 5
hematology, oncology and palliative medicine (5) 5
lymphoma, large b-cell, diffuse - drug therapy (5) 5
medicine (5) 5
melphalan (5) 5
quality of life (5) 5
risk factors (5) 5
rituximab plus cyclophosphamide (5) 5
stem-cell transplantation (5) 5
survival (5) 5
survival analysis (5) 5
thalidomide - administration & dosage (5) 5
transplantation (5) 5
vincristine - therapeutic use (5) 5
analysis (4) 4
bendamustine plus rituximab (4) 4
biopsy (4) 4
case report (4) 4
chemotherapy plus rituximab (4) 4
clinical neurology (4) 4
clinical trials as topic (4) 4
cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus (4) 4
dosage and administration (4) 4
doxorubicin - administration & dosage (4) 4
drugs (4) 4
follow-up studies (4) 4
gene expression (4) 4
health aspects (4) 4
hemic and lymphatic diseases (4) 4
human (4) 4
hypertension (4) 4
immunohistochemistry (4) 4
immunology (4) 4
lymphocytes b (4) 4
lymphoma, large b-cell, diffuse - mortality (4) 4
medical colleges (4) 4
medical prognosis (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medicine (Baltimore), ISSN 0025-7974, 06/2020, Volume 99, Issue 25, pp. e20832 - e20832
.... This research will assess the effectiveness and safety of thymectomy plus prednisone compared to prednisone monotherapy for the treatment of non-thymomatous MG systematically. Methods... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Medical colleges | Care and treatment | Safety and security measures | Corticosteroids | Myasthenia gravis | Analysis | Medicine, Chinese | Prednisone | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2017, Volume 376, Issue 14, pp. 1311 - 1320
Journal Article
Cancer, ISSN 0008-543X, 01/2003, Volume 97, Issue 1, pp. 21 - 29
Journal Article
Blood, ISSN 1528-0020, 01/2009, Volume 113, Issue 4, pp. 775 - 783
Differentiation syndrome (DS) can be a life-threatening complication in patients with acute promyelocytic leukemia (APL) undergoing induction therapy with... 
anthracycline plus retinoic acid | drug combination | major clinical study | treatment duration | creatinine blood level | review | outcome assessment | female | add on therapy | clinical trial | preschool child | idarubicin | leukocyte count | recurrent disease | treatment outcome | article | retinoic acid | anthracycline | mercaptopurine | differentiation syndrome | adolescent | adult | prednisone | correlational study | male | child | mitoxantrone | acute kidney failure | unclassified drug | pathology | methotrexate | creatinine | syndrome | priority journal | disease free survival | disease severity | human | dexamethasone | disease course | aged | middle aged | prognosis | risk factor | comorbidity | controlled study | retinoic acid syndrome | mortality | promyelocytic leukemia | diuretic agent | time | drug withdrawal | incidence | Life Sciences & Biomedicine | Hematology | Science & Technology | Recurrence | Leukemia, Promyelocytic, Acute - pathology | Prognosis | Humans | Middle Aged | Risk Factors | Child, Preschool | Male | Syndrome | Disease-Free Survival | Tretinoin - therapeutic use | Time Factors | Adolescent | Aged, 80 and over | Adult | Female | Aged | Leukemia, Promyelocytic, Acute - complications | Anthracyclines - therapeutic use | Drug Therapy, Combination | Child | Leukemia, Promyelocytic, Acute - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 12/2014, Volume 167, Issue 5, pp. 608 - 617
Journal Article
Oncology letters, ISSN 1792-1074, 02/2018, Volume 15, Issue 2, pp. 1707 - 1715
...) L265P in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP... 
Myeloid differentiation factor 88 L265P | Rituximab plus cyclophosphamide | Allele-specific semi-nested polymerase chain reaction | Prednisone | Doxorubicin | Vincristine | Diffuse large B-cell lymphoma | Life Sciences & Biomedicine | Oncology | Science & Technology
Journal Article
Journal Article